Peptide and Protein-Based Drug Chemistry

Peptide-based therapeutics offer high specificity and biological potency. Engineered peptide agonists enhance receptor activation in glucose-regulating pathways. Increasing protease resistance extends circulation time and therapeutic durability. Optimized secondary structure improves molecular stability during storage and administration. Enhanced receptor selectivity minimizes off-target interactions.

Peptide Engineering Framework:

  • Stability Enhancement Methods
  • Structural Optimization
  • Receptor Binding Control

    Related Conference of Peptide and Protein-Based Drug Chemistry

    May 24-25, 2027

    23rd World Congress on Structural Biology

    Paris, France

    Peptide and Protein-Based Drug Chemistry Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in